Table 1.
Total | Responder (n = 93) |
Non-responder (n = 18) |
p-value | |
---|---|---|---|---|
Age, years | 63.12 ± 4.83 | 63.04 ± 4.67 | 63.50 ± 5.70 | 0.715 |
PSA, ng/ml | 3.42 ± 0.93 | 3.42 ± 0.93 | 3.43 ± 0.96 | 0.946 |
IPSS total score | ||||
Baseline | 24.03 ± 2.49 | 24.26 ± 2.46 | 22.83 ± 2.38 | |
At 4 weeks | 16.41 ± 3.84 | 15.14 ± 1.95 | 23.00 ± 4.49 | |
p-value | < 0.001 | < 0.001 | 0.815 | |
Qmax (ml/sec) | ||||
Baseline | 7.72 ± 1.64 | 7.64 ± 1.66 | 8.14 ± 1.49 | |
At 4 weeks | 12.08 ± 2.37 | 12.59 ± 1.71 | 9.47 ± 3.45 | |
p-value | < 0.001 | < 0.001 | 0.097 | |
PVR (ml) | ||||
Baseline | 108.84 ± 36.38 | 110.78 ± 15.38 | ||
At 4 weeks | 60.02 ± 24.40 | 104.14 ± 42.88 | ||
p-value | < 0.001 | 0.524 | ||
QoL | ||||
Baseline | 4.68 ± 0.77 | 4.69 ± 0.78 | 4.61 ± 0.69 | |
At 4 weeks | 4.08 ± 0.97 | 4.10 ± 0.99 | 3.89 ± 1.02 | |
p-value | < 0.001 | < 0.001 | 0.010 |
*t-test
**Paired Samples Correlations